Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Expanding evidence leads to new pharmacogenomics payer coverage.

Literature DB >> 33627827

Expanding evidence leads to new pharmacogenomics payer coverage.

Philip E Empey¹, Victoria M Pratt², James M Hoffman^3,4, Kelly E Caudle⁴, Teri E Klein⁵.

Abstract

Entities: Chemical

Mesh：
Humans
Pharmacogenetics

Year: 2021 PMID： 33627827 PMCID： PMC8222707 DOI： 10.1038/s41436-021-01117-w

Source DB: PubMed Journal: Genet Med ISSN： 1098-3600 Impact factor: 8.822

× No keyword cloud information.

2 in total

1. Documenting Pharmacogenomic Testing with CPT Codes.

Authors: Erik Hefti; Javier G Blanco
Journal: J AHIMA Date: 2016-01

2. Delivering on the value proposition of precision medicine: the view from healthcare payers.

Authors: Jane Null Kogan; Philip Empey; Justin Kanter; Donna J Keyser; William H Shrank
Journal: Am J Manag Care Date: 2018-04 Impact factor: 2.229

2 in total

13 in total

1. Pharmacogenetics: A Precision Medicine Approach to Combatting the Opioid Epidemic.

Authors: D Max Smith; James M Stevenson; Teresa T Ho; Christine M Formea; Roseann S Gammal; Larisa H Cavallari
Journal: J Am Coll Clin Pharm Date: 2021-12-19

Review 2. Advancing Pharmacogenomics from Single-Gene to Preemptive Testing.

Authors: Cyrine E Haidar; Kristine R Crews; James M Hoffman; Mary V Relling; Kelly E Caudle
Journal: Annu Rev Genomics Hum Genet Date: 2022-05-10 Impact factor: 9.340

3. Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing DPYD and UGT1A1 Screening to Guide Chemotherapy Dosing.

Authors: Lisa A Varughese; Madhuri Bhupathiraju; Glenda Hoffecker; Shannon Terek; Margaret Harr; Hakon Hakonarson; Christine Cambareri; Jessica Marini; Jeffrey Landgraf; Jinbo Chen; Genevieve Kanter; Kelsey S Lau-Min; Ryan C Massa; Nevena Damjanov; Nandi J Reddy; Randall A Oyer; Ursina R Teitelbaum; Sony Tuteja
Journal: Front Oncol Date: 2022-07-05 Impact factor: 5.738

10. Documenting Pharmacogenomic Test Results in Electronic Health Records: Practical Considerations for Primary Care Teams.

Authors: Roseann S Gammal; Lucas A Berenbrok; Philip E Empey; Mylynda B Massart
Journal: J Pers Med Date: 2021-12-04

Expanding evidence leads to new pharmacogenomics payer coverage.

1. Documenting Pharmacogenomic Testing with CPT Codes.

2. Delivering on the value proposition of precision medicine: the view from healthcare payers.

1. Pharmacogenetics: A Precision Medicine Approach to Combatting the Opioid Epidemic.

Review 2. Advancing Pharmacogenomics from Single-Gene to Preemptive Testing.

3. Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing DPYD and UGT1A1 Screening to Guide Chemotherapy Dosing.

4. Survey of US Medical Oncologists' Practices and Beliefs Regarding DPYD Testing Before Fluoropyrimidine Chemotherapy.

5. The Value of Pharmacogenetics to Reduce Drug-Related Toxicity in Cancer Patients.

Review 6. Moving Pharmacogenetics Into Practice: It's All About the Evidence!

Review 7. Pharmacogenomic Clinical Decision Support: A Review, How-to Guide, and Future Vision.

8. Revisiting UGT1A1 Pharmacogenetic Testing Before Irinotecan-Why Not?

9. An Investigation of the Knowledge Overlap between Pharmacogenomics and Disease Genetics.

10. Documenting Pharmacogenomic Test Results in Electronic Health Records: Practical Considerations for Primary Care Teams.